Tag: American Association of Kidney Patients
FDA approves CorMedix Inc. DefenCath to reduce the incidence of catheter-related...
The US Food and Drug Administration (FDA) has approved CorMedix’s DefenCath, the first and only antimicrobial catheter lock solution (CLS) in the USA to...
Industry leaders agree patients are key to kidney care innovation at...
This year's American Association of Kidney Patients (AAKP) policy summit highlighted the challenges and opportunities for researchers and companies involved in safely bringing new,...